Role of Nutrition in the Etiopathogenesis and Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in a Group of Obese Adults

被引:3
|
作者
Metro, Daniela [1 ]
Buda, Martina [2 ]
Manasseri, Luigi [1 ]
Corallo, Francesco [3 ]
Cardile, Davide [3 ]
Lo Buono, Viviana [3 ]
Quartarone, Angelo [3 ]
Bonanno, Lilla [3 ]
机构
[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, I-98122 Messina, Italy
[2] UOC Gen Surg Oncol, Dept Oncol DAI, I-98125 Messina, Italy
[3] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113 Via Palermo, I-98124 Messina, Italy
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 03期
关键词
NAFLD; micronutrients; Mediterranean diet; transaminases; prevention; cognitive impairment; cognitive rehabilitation; VITAMIN-E; INFLAMMATORY BIOMARKERS; INSULIN-RESISTANCE; GENE-EXPRESSION; CARBOHYDRATE; DIET; RECOMMENDATIONS; EPIDEMIOLOGY; PATHOGENESIS; FRUCTOSE;
D O I
10.3390/medicina59030638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is liver damage characterized by an accumulation of triglycerides in hepatocytes of >5% (due to an alteration of the balance of the lipid metabolism in favour of lipogenesis compared to lipolysis) that is not induced by the consumption of alcohol. The pathology includes simple steatosis and nonalcoholic steatohepatitis, or NASH (steatosis associated with microinflammatory activities), which can evolve in 15% of subjects with hepatic fibrosis to cirrhosis and the development of hepatocellular carcinoma. The aim of this study is to report the role of macro- and micronutrients in the pathogenesis and prevention of NAFLD in obese subjects. A total of 22 obese or overweight patients with hepatic steatosis were monitored periodically, evaluating their eating habits, fasting glycaemia, lipid picture, liver enzymes, anthropometric parameters, nutrition status, liver ultrasound, oxidative stress, and adherence to the Mediterranean diet. A statistical analysis shows a significant positive relationship between total cholesterol and the Mediterranean adequacy index (MAI) (r = -0.57; p = 0.005) and a significant negative relationship between ALT transaminases and the MAI (r = -0.56; p = 0.007). Nutrition and diet are important factors in the pathogenesis and prevention of NAFLD. The dietary model, based on the canons of the Mediterranean diet, prevents and reduces the accumulation of fat in hepatocytes. Therefore, in agreement with other studies in the literature, we can state that a dietary model characterized by foods rich in fibre, carotenoids, polyphenols, omega 3 fatty acids, folic acid, and numerous other molecules is inversely correlated with the serum levels of ALT transaminases, an enzyme whose level increases when the liver is damaged and before the most obvious symptoms of organ damage appear.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Role of Fatty Acid Desaturase 1 (FADS1) in Nonalcoholic Fatty Liver Disease (NAFLD)
    Athinarayanan, Shaminie
    Fan, Yang-Yi
    Chapkin, Robert
    Liu, Wanqing
    HEPATOLOGY, 2015, 62 : 236A - 236A
  • [42] Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
    Kaswala, Dharmesh H.
    Lai, Michelle
    Afdhal, Nezam H.
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (05) : 1356 - 1364
  • [43] BENEFITS OF AN INTERVENTION CONCEPT FOR WEIGHT REDUCTION IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN OVERWEIGHT ADULTS
    Koohkan, S.
    Schaffner, D.
    Deibert, P.
    Koenig, D. .
    Berg, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A92 - A92
  • [44] Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD)
    Xin, Xin
    Chen, Cheng
    Hu, Yi-Yang
    Feng, Qin
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [45] Nonalcoholic fatty liver disease (NAFLD): Approach in the adolescent patient
    Roberts E.A.
    Yap J.
    Current Treatment Options in Gastroenterology, 2006, 9 (5) : 423 - 431
  • [46] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Ajay Duseja
    Naga Chalasani
    Hepatology International, 2013, 7 : 755 - 764
  • [47] THE NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) CONUNDRUM: HOW TO DEFINE IT?
    Mato, J. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 5 - 5
  • [48] Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging
    Koch, Lisa K.
    Yeh, Matthew M.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 37 : 83 - 90
  • [49] Burden of Nonalcoholic Fatty Liver Disease (NAFLD) in the United States
    Sanyal, Arun J.
    Estes, Chris
    Razavi, Homie
    HEPATOLOGY, 2016, 64 : 532A - 532A
  • [50] The histological features of pediatric nonalcoholic fatty liver disease (NAFLD).
    Schwimmer, JB
    Behling, C
    Newbury, R
    McGreal, N
    Rauch, J
    Deutsch, R
    Lavine, JE
    HEPATOLOGY, 2002, 36 (04) : 412A - 412A